Mapping of the Sites for Ligand Binding and Receptor Dimerization at the Extracellular Domain of the Vascular Endothelial Growth Factor Receptor FLT-1*
- Bernhard Barleon,
- Frank Totzke,
- Christel Herzog,
- Stephen Blanke,
- Elisabeth Kremmer‡,
- Gerhard Siemeister,
- Dieter Marmé and
- Georg Martiny-Baron§
- From the Institute of Molecular Medicine, Tumor Biology Center, D-79106 Freiburg, Germany and ‡GSF-Forschungszentrum, D-81377 München, Germany
Abstract
The vascular endothelial growth factor (VEGF) receptor FLT-1 has been shown to be involved in vasculogenesis and angiogenesis. The receptor is characterized by seven Ig-like loops within the extracellular domain. Upon VEGF binding FLT-1 becomes phosphorylated, which has been thought to be preceded by receptor dimerization. To further investigate high affinity binding of VEGF to FLT-1 and ligand-induced receptor dimerization, we expressed in Sf9 cells the entire extracellular domain comprising all seven Ig-like loops: sFLT-1(7) and several truncated mutants consisting of loop one, one and two, one to three, one to four, and one to five. The corresponding proteins, named sFLT-1(1), (2), (3), (4), and (5) were purified. Only mutants sFLT-1(3) to (7) were able to bind125I-VEGF with high affinity. No binding of VEGF was observed with sFLT-1(1) and sFLT-1(2), indicating that the first three Ig-like loops are involved in high affinity binding of VEGF. The binding of VEGF to sFLT-1(3) could be competed with placenta growth factor (PlGF), a VEGF-related ligand, suggesting that high affinity binding of VEGF and PlGF is mediated by the same or closely related contact sites on sFLT-1. Deglycosylation of the sFLT-1(3), (4), (5), and (7) did not abolish VEGF binding. Furthermore, unglycosylated sFLT-1(3), expressed in Escherichia coli, was able to bind VEGF with similar affinity as sFLT-1(3) or sFLT-1(7), both expressed in Sf9 cells. This indicates that receptor glycosylation is not essential for high affinity binding. Dimerization of the extracellular domains of FLT-1 upon addition of VEGF was detected with all mutants containing the Ig-like loop four. Although sFLT-1(3) was able to bind VEGF, dimerization of this mutant was inefficient, indicating that sites on Ig-like loop four are essential to stabilize receptor dimers.
Footnotes
-
↵* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵§ To whom correspondence should be addressed: Institute of Molecular Medicine, Tumor Biology Center, Breisacher Str. 117, D-79106 Freiburg, Germany. Tel.: 49 761-206 1740; Fax: 49 461-206 1705.
-
↵1 The abbreviations used are: VEGF, vascular endothelial growth factor; FLT-1, fms-like tyrosine kinase-1; PlGF, placenta growth factor; PDGF, platelet-derived growth factor; HUVEC, human umbilical vein endothelial cell; DSS, disuccinimidyl suberate; PBS, phosphate-buffered saline; MES, 4-morpholineethanesulfonic acid; PAGE, polyacrylamide gel electrophoresis; mAb, monoclonal antibody; bp, base pair(s); sFLT, soluble FLT.
-
- Received October 3, 1996.
- Revision received December 26, 1996.











